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High-risk types of human papillomavirus (HPV) are responsible for nearly all instances of 
cervical cancer, and a significant proportion of head and neck cancers. Studying HPV in 
the laboratory requires the cultivation of host keratinocytes to facilitate the viral lifecycle. 
In addition, HPV will not completely undergo its lifecycle in monolayer cell culture, but 
requires the differentiation process of keratinocytes. This can be accomplished by 
employing organotypic raft cultures, which simulates full-thickness skin in vitro. Though 
this method can reproduce the viral lifecycle, there are still numerous hurdles when 
modelling disease. In the first phase of this study, we utilize published methods to culture 
cervical keratinocytes from 25 different cervical lesion biopsies, establishing cultures from 
8 (~32%). Biopsy specimens were digested with collagenase I and grown in keratinocyte 
growth medium (KGM) containing 5% fetal bovine serum for 4 days, after which, cultures 
were switched to serum-free KGM to avoid fibroblast overgrowth. The median in vitro 
lifespan of cultures was 4 weeks, which typically yielded less than a confluent T-75 of 
cells. In the second phase of this study, the media was switched from KGM to EpiLife, 
which has more organic components, and contains insulin-like growth factor I in place of 
insulin, which has more mitogenic potential and increases keratinocyte lifespan in vitro. 
Biopsies were processed under the same conditions, and after removing the media 
containing 5% serum, the Rho-associated kinase (ROCK) inhibitor Y-27632 was added to 
EpiLife media to further increase culture lifespan. Cultures were established from 6 of 14 
(~42%) newly acquired biopsies, 4 of which survived for several passages (range 2-7) 
across T-75 flasks (flasks seeded at 10% confluence and passaged when >80% confluent). 
The improved culture conditions effectively halved the doubling time, but maintained 
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approximately the same culture lifespan (median 4.5 weeks). Organotypic raft cultures 
were prepared using 5 different patient samples; most had differentiated at the time of 3D 
culturing, while others yielded only a few cell layers upon cross sectioning and H&E 
staining. Future work will improve upon our culture media formulations to facilitate 






















Human papillomavirus (HPV) is a virus that infects cells of the skin and mucosa. HPV is 
the infectious agent responsible for warts, and notably, HPV is also responsible for nearly 
all instances of cervical cancer. Studying HPV in the laboratory requires the culture of its 
host cells – called keratinocytes. Human keratinocytes grown in the laboratory are typically 
acquired from neonatal foreskins. This tissue is readily accessible and would otherwise be 
discarded, making it both practical and ethical means of acquiring keratinocytes. Though 
the virus can replicate within these cells under the appropriate conditions, cervical 
keratinocytes would be a more accurate model for studying HPV-mediated cervical cancer. 
In this study, we expanded upon published methods to culture keratinocytes from cervical 
biopsy specimens. In the first phase of this study we established 8 cultures from 25 biopsy 
specimens, with the median culture actively growing for 4 weeks. Most of these cultures 
did not proliferate enough for further experimentation. Therefore, the second phase of this 
study sought to increase culture lifespan. We replaced our media with EpiLife, a 
formulation which is rated for more than twice as many population doublings. We also 
added the protein kinase inhibitor Y-27632 which prevents keratinocyte differentiation, 
thereby increasing their lifespan. We established cultures from 6 of 14 newly enrolled 
patients. Median survival was modestly increased to 4.5 weeks, but the doubling time was 
nearly halved. Most of these cultures proliferated enough to be utilized in further 
experimentation. We attempted to reconstruct these cells into 3-dimensional cultures in 
vitro, to simulate patient lesions – albeit with limited success. Future work will improve 
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1.1 Human papillomavirus literature review 
1.1.1 General overview of human papillomavirus and disease 
Human papillomavirus (HPV) is a double-stranded DNA virus that infects 
keratinocytes of the skin and mucosa (zur Hausen, 2002). To date, over 200 distinct types 
of HPV have been recognized (de Villiers, 2013; Papillomavirus Episteme 
<https://pave.niaid.nih.gov/#home>), which are broadly categorized as high- or low-risk 
types based on their ability to cause cancer. The most clinically significant high-risk type 
is HPV16, which accounts for approximately half of all HPV-related cervical and a 
significant portion of head and neck cancer cancers (Crow, 2012). Possessing a small 
circular genome of ~7900 base pairs, HPV16 has eight genes, some of which contain splice 
variants (Zheng and Baker, 2006). The most notable of these viral genes are the two 
oncogenes: E6 and E7. In HPV16, the E6 oncoprotein facilitates the degradation of the host 
tumour-suppressor p53, while also increasing telomerase expression; thereby inhibiting 
apoptosis and facilitating cellular immortalization. The E7 oncoprotein mediates 
degradation of pRB, promoting entry into the cell-cycle (Klingelhutz and Roman, 2012). 
Together, E6 and E7 promote cellular transformation and subsequent tumourigenesis. 
 
1.1.2 HPV viral life cycle, histological changes, and cancer 
 The HPV virions infect basal keratinocytes through epidermal micro-abrasions (zur 
Hausen, 2002), where basal keratinocytes are the actively dividing cells in the epithelium. 
As early genes, E6 and E7 inhibit apoptosis and maintain cellular division, as stated 
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previously (Figure 1A). Early during infection, E1 and E2 maintain low-level viral genome 
replication, while E2 also modulates host and viral transcription (Frattini and Laimins, 
1994; Wilson et al., 2002). Later into the viral life cycle, E4 (Peh et al., 2004) and E5 
(Genther et al., 2003) further promote viral genome amplification, and viral particles are 
assembled with the major- and minor-capsid proteins L1 and L2, respectively. Assembled 
HPV virions are then shed from the cornified layer. 
 HPV inhibits the differentiation of keratinocytes, which has numerous histological 
corollaries of both clinical and experimental significance. Physiological differentiation 
triggers keratin switching in the epithelial layer, Keratin 5 (K5) expression is high in the 
basal layer (Moll et al., 1982); Keratin 10 (K10) and involucrin expression begins in the 
spinous layer and continues through to the cornified layer (Strudwick et al., 2015; Figure 
1B). Therefore, HPV infection will increase the spatial expression of K5 past the basal 
layer, and impede the expression of K10 and involucrin at the spinous layer. This abrogated 
differentiation is accompanied by the retention of cell nuclei beyond the basal layer. These 
biomarkers can be stained for via immunohistochemistry (IHC) in both patient biopsy 
specimens, and organotypic raft cultures growth in vitro (described below). Of clinical 






Figure 1. Spatial expression of HPV viral genes during infection of skin. HPV virions 
infect basal keratinocytes through micro-abrasions (A). The viral oncogenes E6 and E7 
inhibit apoptosis and promote entry into the cell cycle, while E1 and E2 maintain low-level 
viral genome replication. The viral genes E4 and E5 promote viral genome amplification 
and assemble with the capsid proteins L1 and L2. Viral particles are released as cells slough 
off (modified from Kajitani et al., 2012). Spatial expression of biomarkers markers during 






 Clinical biomarkers – those used to assess cervical lesion progression – are 
typically related to cell cycle regulation. The most commonly assessed is the cyclin-
dependant kinase inhibitor p16INK4a. Increased p16INK4a expression is a consequence of E7-
mediated disruption of pRB (Wentzensen et al., 2007). Other tests exist to detect for 
aberrant S-phase induction, namely topoisomerase IIA (TOP2A) and minichromosome 
maintenance protein 2 (MCM2; Halloush et al., 2008). Increases in p16INK4a, TOP2A, or 
MCM2 indicates a lesion progressing to high-grade. These tests are generally combined 
with hemotoxylin and eosin (H&E) staining of patient biopsy sections to help evaluate the 
neoplastic lesion. Figure 2 illustrates the infection process, low- to high- grade lesion 
progression, and finally invasive cancer. Of course, other prognostic markers relating to 
the virus itself are occasionally tested. HPV typing can determine if a patient is infected 
with a high-risk HPV type, as well elevated expression levels of the E6 and E7 oncogenes 
(Cattani et al., 2009). Also, as integration of the viral episome into the host genome is 
present in the majority of cervical carcinomas, testing for integration status may also 





Figure 2. Cervical lesion progression towards cancer. HPV infects basal keratinocytes 
through a micro-abrasion. Infection prevents keratinocyte differentiation, causing cells to 
retain their nuclei for longer, producing viral particles. In most instances of HPV-mediated 
carcinogenesis, the viral genome integrates into the host genome. Overexpression of E6 
and E7 promotes the progression of high-grade lesions towards invasive carcinoma 
(Woodman et al., 2007). 
 
1.1.3 Organotypic raft culture 
 Organotypic raft cultures are three-dimensional cultures which simulate full-
thickness skin, created from monolayer cultures grown entirely in vitro (Bell et al., 1981). 
Organotypic raft cultures can be constructed using primary cell lines, immortalized cell 
lines, or both. They consist of a simulated dermis containing fibroblast cells, and a 
keratinocyte monolayer seeded on top; grown at an air-liquid interface to facilitate 
epithelialization. Different methods utilize primary (Jackson et al., 2014) or immortalized 
fibroblasts (Pickard et al., 2015), in combination with primary or immortalized 
keratinocytes (Strudwick et al., 2015), whereby mucosal keratinocytes can also be utilized 
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to model mucosal epithelium (Dongari-Bagtzoglou and Kashleva, 2006). Importantly, raft 
cultures can model normal and dysplastic epithelium (Blanton et al., 1991), and have also 
been employed to study numerous viruses besides HPVs, including poxviruses (Duraffour 
et al, 2007), Epstein-Barr virus (Dawson et al., 1998), and herpes simplex virus (Hukkanen 
et al., 1999). For HPV, the raft model is not only permissive to the differentiation-
dependant viral life-cycle (Meyers et al., 1992; Flores et al., 1999), it has even been shown 
to reproduce epithelial invasion of the dermis when using E6/E7 transduced cell lines 
(Pickard et al., 2015). In this respect, it may be possible to use raft cultures to model lesion 
progression and early invasion, using patient-derived cell lines. Raft cultures have 
additional uses when studying viral exanthems, as they maintain many pathogen-host 
interactions while bypassing the need for animal models. Indeed, organotypic raft cultures 
have been used to test antiviral drugs against herpes viruses (Andrei, 2005) and poxviruses 
(Duaffour et al., 2007), as well as topical treatments for head and neck squamous cell 
carcinoma (Eicher et al., 1996). It would seem feasible then, to test new antiviral agents 
against HPV in organotypic raft cultures. 
 
1.1.4 Establishment of cervical keratinocyte cell cultures 
 Primary neonatal foreskin keratinocytes are the most commonly utilized human 
keratinocyte in the laboratory. Foreskins are easy to acquire – both practically and ethically 
speaking – and a foreskin can yield many more cells over a biopsy. Ideally when studying 
cervical cancer, a researcher would obviously utilize cervical cells. There are two means 
to acquire primary cervical cells: 1) isolate and culture normal cervical keratinocytes from 
a healthy cervix, and introduce HPV experimentally; and 2) propagate cells derived from 
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naturally-infected cervical lesion biopsies. Unfortunately, there are numerous practical and 
ethical hurdles when establishing cultures of normal primary cervical keratinocytes. First 
and foremost, it is unethical to acquire apparently healthy cervical tissue by biopsying a 
patient, as this introduces unnecessary risks, especially as many patients are of reproductive 
age. Therefore, the ideal means of acquiring healthy cervical tissue is from a total 
hysterectomy, which completely removes the uterus, cervix, and ovaries. Acquiring 
cervical tissue from a total hysterectomy has many practical challenges however, and 
requires the direct collaboration of the obstetrician/gynecologist performing the procedure 
and the acting pathologist, which ensures the patient’s standard-of-care without formalin-
fixing the still-living tissue. 
The most practical and ethical means of acquiring cervical cells is to take biopsy 
specimens from patient lesions, while the physician is already taking a sample for standard-
of-care. Given that cervical cancer results from persistent HPV infections, this approach 
would seem ideal for modelling and studying progression of cervical lesions. There are 
however, numerous methodological hurdles to establishing an in vitro culture of 
keratinocytes from biopsy specimens. These issues can include – but are not limited to –  
microbial contamination, fibroblast contamination (Stanley, 2002), low cellular viability 
and/or yield, and limited culture lifespan (Schweinfurth and Meyers, 2006). Previous 
studies have demonstrated low colony forming efficiency (Bononi et al., 2012), limited 
potential to passage cultures (Liu et al, 2013), and low adherence of viable cells (Liu et al, 
2016). Even with established methods, cultures from HPV lesions may be established from 
less than one-third of biopsy specimens and possess a limited lifespan in vitro 
(Schweinfurth and Meyers, 2006). Currently, there is no literature on generating 
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organotypic rafts from patient-derived, naturally-infected cervical keratinocytes. 
 
1.1.5 Surveillance and intervention of cervical lesions 
 The vast majority of cervical HPV infections clear up naturally within three years 
(Ho et al., 1998). A patient’s standard-of-care is to have their cervical lesion monitored 
through Papanicolaou tests and colposcopy exams, rather than to surgically intervene at the 
first sight of a lesion. In Canada, for patients possessing a cervical intraepithelial neoplasia 
(CIN) grade II or III lesion, this entails a 6-month follow-up examination and subsequent 
biopsy (Bentley J et al., 2012). For lesions that do not regress, the physician may decide to 
perform a loop electrosurgical excision procedure (LEEP) to remove the dysplastic tissue. 
Unfortunately, lesions can recur in as many as 30% of cases (Gonzalez et al., 2001). The 
prevalence of these actively surveyed lesions remains an untapped temporal window for 
treatment. It would seem prudent to develop a non-invasive antiviral therapy that could 
reduce lesion grade, reduce colposcopy visits, and/or reduce the number of surgical 
interventions. One possible treatment would be the use of RNA interference (RNAi), which 
targets mRNA transcripts for degradation, abrogating a gene’s ultimate translation 
(described below). RNAi is an active area of research for many therapeutics, but is 
particularly alluring for HPV infection because the viral genes are foreign, and in theory, 
employing RNAi would have minimal effect on healthy cells, or on host gene regulation 
(Jiang and Milner, 2002). In theory, utilizing RNAi to reduce E6 expression could restore 
cellular p53, potentially inducing apoptosis in HPV-infected cells while leaving healthy 




1.1.6 RNA interference and off-target effects 
 RNA interference is an ancient and conserved viral defence mechanism present in 
plants and animals (Fire et al., 1998; Waterhouse et al., 1998). The process of RNAi 
involves the Dicer-mediated cleavage of double-stranded RNA molecules into short 
oligonucleotides approximately 21-23 nt in length (Figure 3). These short oligonucleotides 
–  or small-interfering RNA (siRNA) – are then incorporated into the RNA-induced 
silencing complex (RISC). The activated RISC complex then unwinds the double-stranded 
siRNA, retaining the anti-sense strand (or guide-strand) which is used for targeting mRNA 
transcripts that possess guide-strand complementarity (Nykanen et al., 2001). If the target 
transcript has limited complementarity to the guide-strand, translation of that transcript 
may be inhibited. If the target transcript has near perfect complementarity, the transcript 
will be cleaved by RISC, and subsequently degraded (Hammond et al., 2000). Importantly, 
these siRNA molecules can be processed from double-stranded RNA produced from host 
transcripts, foreign viral genes/genomes, or synthetic oligonucleotides. Therefore, it is 






off-target transcripts can be avoided when designing siRNA oligonucleotides, and 
algorithms exist to predict which host transcripts possess complementarity to siRNA 
oligonucleotides. However, these algorithms are typically designed to predict host 
transcripts that possess near-perfect guide-strand complementarity, and off-targets 
predicted in silico match poorly with those found in vitro (Hanning et al., 2013). Indeed, 
studies have used bioinformatic approaches to show that very few – if any – off-target gene 
transcripts possess significant sequence complementarity to the guide strand (Jackson et 
al., 2003). In fact, only a subset of down-regulated transcripts possess any appreciable 
complementarity to the guide-strand, and these transcripts contain sequence 
complementarity to bases 2 through 8 of the guide strand, termed the ‘seed region’. More 
specifically, these repressed genes were found to contain seed region complementarity 
within their 3’ untranslated region (UTR). Importantly, although 3’-UTR seed matches are 
a robust predictor for off-target effects, they only account for a fraction of transcriptional 
changes observed in response to a given siRNA oligonucleotide (Birmingham et al., 2006). 
This lack of overall predictability merits transcriptomic analysis when elucidating the off-
target effects of any novel siRNA oligonucleotide. 
 Transcriptomic analysis is both expensive and cumbersome, and employing such 
techniques on every siRNA oligonucleotide would be overwhelming. Practically speaking 
however, it is not always necessary to assess all of the off-target effects, but merely to 
demonstrate that the desired cytological/physiological effects are due to the siRNA 
treatment. For many researchers, siRNA oligonucleotides of therapeutic interest are meant 
to induce apoptosis in a diseased or cancerous cell, while inflicting minimal harm on 
healthy cells. In this scenario, it is most prudent to demonstrate that apoptosis is due to the 
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knock-down of the desired gene. When assessing off-target effects in target cells, an 
oligonucleotide very similar in sequence to the query siRNA ought to be used. The C9/11 
control is a rationally designed siRNA control, whereby bases 9 through 11 on the query 
siRNA are altered (Buehler et al., 2012). These base alterations abolish target knock-down, 
while maintaining the vast majority of sequence-specific off-targets. It does this in part by 
retaining the seed-region sequence of the query siRNA. The C9/11 control is therefore 
superior to scrambled siRNA controls. 
 
1.1.7 Previous work in RNA interference 
 In previous work, our research group compared the knock-down efficiency of 
different oligonucleotides designed to target the E6 transcript, with the aims of finding a 
highly potent molecule for abrogating E6 translation, and ultimately restoring p53 (MSc 
Thesis, Jessica Grochowski, 2015; Togtema et al., in press). Oligonucleotides were 
designed to target the E6 splice-site on the E6/E7 transcript, which successfully inhibits E6 
translation but retains translation of E7 (Smotkin et al., 1989). In effect, this should restore 
p53 levels in the presence of the proliferation-promoting E7, which is believed to drive 
infected cells towards apoptosis (McLaughlin-Drubin, 2012). Our lab compared Dicer-
substrate RNA (DsiRNA) to siRNA oligonucleotide molecules that possess the same target 
sequence. In brief, a DsiRNA oligonucleotide feeds into the RNAi pathway further 
upstream than siRNA. As DsiRNA molecules can be significantly more potent than their 
siRNA counterparts (Kim et al, 2005), a DsiRNA molecule was developed based upon a 
corresponding siRNA, to draw direct comparisons. The target sequence within the E6 
splice site was designed using the Rosetta algorithm (Rosetta Inpharmatics Inc.), and we 
found that when tested in the HPV16 cervical cancer cell lines CaSki and SiHa, Rosetta 
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DsiRNA performed better than Rosetta siRNA. Figure 4 summarizes the results obtained 
from previous work using Rosetta DsiRNA. Maximum E6 knock-down occurred between 
10 nM and 250 nM, with no statistical difference between these concentrations. There was 
no statistical difference between incubation times, though 48 appeared maximal for both 









Figure 4. Overview of previous results obtained from E6 knock-down with Rosetta 
DsiRNA. No significant difference between incubation time was found for either cell type 
(n=3, A). Knock-down of E6 was maximal between 10 nM and 250 nM of DsiRNA (n=3, 
B), though there was no significant difference found between these concentrations. Knock-
down of E6 restored p53 as determined by Western blot, though these results were highly 
variable and not statistically significant (n=5, C). Diagram of the RNAi target site within 
the E6 transcript (D). Figure created by Robert Jackson, PhD Candidate, modified from 







1.2 Research rationale 
 When studying HPV in the laboratory, primary neonatal foreskin keratinocytes are 
often employed. Though these keratinocytes are permissive to the viral life cycle (Flores 
et al., 1999), HPV16 is not associated with carcinoma of skin keratinocytes. Utilizing 
cervical keratinocytes from patient-derived cultures is not only a more accurate model to 
the disease in question, but it also permits the modelling of patient variability. Since 
culturing cells from patient biopsies and creating organotypic cultures is not a trivial task, 
the goal of this work is simply to develop methods to do so. Similarly, because we wish to 
develop RNAi therapeutics, patient-derived cells can not only be utilized to model patient-
specific responses, they would also be more accurate models than the highly transformed 
immortalized cancer cell lines. Based on our previous work on DsiRNA E6 knock-down 
in HPV16 cancer cell lines (Togtema et al., in press), we would like to continue our 
experimental algorithm by assessing the downstream effects of E6 knock-down, at the level 
of gene expression, viability, and apoptosis. 
 
1.3 Hypotheses 
Given the results of Schweinfurth et al. (2006) and Liu et al. (2016), and the 
potential issues listed by Stanley (2002), we expect: 
1. Roughly 10-30% of established cultures will succumb to microbial 
contamination. 
2. The longest cultures will grow for 6 to 8 weeks. 
3. After utilising 5-10 samples to establish our methodology, we may see a 30% 
success rate in establishing cultures. 
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In previous work, we assessed E6 knock-down in HPV16 positive cancer cell lines, 
and found that p53 restoration was limited in SiHa, and highly variable in CaSki (Figure 
4). Additionally, there was no statistical difference in E6 knock-down between 10 nM and 
250 nM DsiRNA treatments. Therefore, we utilized DsiRNA between 2.5 nM and 10 nM 
for further experiments. This concentration range was also believed to span the median 
inhibitory concentration, as well, these lower concentrations are considered more clinically 
relevant (Persengiev et al., 2004). Despite 10 nM providing near-maximal E6 knock-down, 
it may still be insufficient to restore cellular processes. We will also include a C9/11 
DsiRNA for a control, but overall we may expect: 
1. hTERT levels will decrease because E6 levels are notably reduced. 
2. E7 levels will remain relatively unchanged, as Rosetta DsiRNA targets the 
splice site. 
3. Downstream effects of p53 restoration will be unchanged from controls. 
4. Cellular viability and growth will be unchanged. 
 
1. Materials and Methods 
 
2.1 Materials and methods for downstream effects of E6 knock-down 
2.1.1 Cell culture and maintenance 
Cell cultures were maintained in a humidified incubator at 37°C with 5% CO2. The cervical 
cancer cell lines CaSki (ATCC, Cat. No. CRL-1550) and SiHa (ATCC, Cat. No. HTB-35) 
were cultured in Dulbecco's Modified Eagle's Medium (DMEM; Fisher Scientific, Cat. No. 
SH30243.01) containing 10% heat-inactivated fetal bovine serum (FBS; Fisher Scientific, 
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Cat. No. SH30396.03) and 1X antibiotic/antimycotic (Fisher Scientific, Cat. No. 
SV3007901). When passaging cultures, cells were washed with Dulbecco's Phosphate 
Buffered Saline (DPBS; Fisher Scientific, Cat. No. SH30028.02) before adding 2 ml of 
0.05% trypsin containing 0.02% ethylenediaminetetraacetic acid (Trypsin-EDTA; Fisher 
Scientific, Cat. No. SH3023602), and incubated at 37°C for 5-10 minutes until cells were 
sufficiently detached. At which point, 4 ml of culture media was added to inactivate the 
trypsin. Cultures were seeded at 10% confluency and maintained up to 80% confluence 
before subsequent passaging. 
 
2.1.2 Cryogenic storage and retrieval 
When preparing stocks for cryogenic storage, cells were trypsinized as described and 
quantified using a TC10™ Automated Cell Counter (Bio-Rad, Cat. No. 145-0009). Cells 
were then pelleted at 750 rpm for 5 minutes, and then resuspended in the appropriate 
volume of 90% DMEM-FBS and 10% dimethyl sulfoxide (DMSO; Sigma-Aldrich, Cat. 
No. 34869) to achieve 1 x 106 cells per ml, preparing 1 ml stocks. Stocks were then frozen 
using a controlled-rate cooling container (Thermo Fisher Scientific, Cat. No. 5100-0001) 
at -80°C. Frozen vials were subsequently stored in liquid nitrogen for long-term use. 
When retrieving cell stocks from cryogenic storage, vials were thawed to room 
temperature and added to 4 ml of DMEM-FBS. The cells were pelleted at 750 rpm and the 
media was aspirated. Cell pellets were re-suspended in 10 ml of media and plated onto T-





2.1.3 Mycoplasma testing 
Cultures of CaSki and SiHa cells were regularly tested for Mycoplamsa contamination by 
fluorescent staining with 4'-6-diamidino-2-phenylindole (DAPI). Approximately 1 x 104 
cells were seeded onto sterile glass cover slips (Thermo Fisher Scientific, Cat. No. 12-
541A) and grown in 35mm cultures dishes for 2-3 days. At which point, the media was 
removed and cells were fixed using Carnoy's fixative (3:1 solution of methanol (Thermo 
Fisher Scientific, Cat. No. A4544) and glacial acetic acid (Sigma-Aldrich, Cat. No. 
695092-2.5L), respectively). Fixative was first added to cells for 5 minutes, the fixative 
was then removed, and fresh fixative was added for another 10 minutes. The cover slips 
were removed and allowed to air dry. Cover slips were then mounted on a microscope slide 
using Vectashield Mounting Medium containing DAPI (1.5 µg/mL, Vector Laboratories. 
Cat. No. H-1200). This method stains the DNA of Mycoplasma thereby permitting their 
visualization within the cytoplasm of infected cells via fluorescent microscopy. 
 
2.1.4 C9/11 design and validation 
 A control DsiRNA was designed in which bases 9 through 11 of the guide strand 
were altered to create three consecutive mismatches against the E6 transcript: termed the 
C9/11 control (Buehler et al., 2012). It has been shown that a single base mutation at 
nucleotides in the 9th, 10th, 11th, or 12th position can abolish target-mRNA knock-down by 
up to 90% (Birmingham et al., 2006). By combining three consecutive mismatches, it can 
be ensured that target sequence knock-down is abolished, and off-targets are retained. This 
C9/11 control siRNA can then be used as a direct comparison for the observed downstream 
effects, such as apoptosis. This instills confidence in scientific results that typical 
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scrambled control siRNA cannot (Buehler et al., 2012). Each mismatch-causing nucleotide 
was selected based off of its ideal knock-down abrogating potential as described in 
Birmingham et al. (2006).  
The Rosetta DsiRNA pre-processing guide-sequence 5'-
AUCUCUAUAUACUAUGCAUAAAUCCCG-3' was changed to sequence 5'-
AUCUCUAUAUACUAACAAUAAAUCCCG-3', underlining to indicate base changes. 
To validate that the C9/11 control has abrogated E6 knock-down, CaSki and SiHa cells 
were seeded into T-25 flasks and transfected with the C9/11 DsiRNA. Cell culture, 
transfection, harvesting, and RT-qPCR analyses were performed using parameters 
described below. 
 
2.1.5 Chemical transfections and cell harvesting 
 Cells were seeded into T-25 flasks at 3.5 x 105 cells per flask for CaSki, and 1.5 x 
105 cells per flask for SiHa. After 24 hours, the media was changed with 4 ml of fresh 
DMEM-FBS, and cultures were transfected with DsiRNA complexes to a final 
concentration of 2.5, 5 or 10 nM of Rosetta E6 DsiRNA or the corresponding C9/11 control 
DsiRNA. Transfection complexes consisted of 1 ml total of serum-free DMEM, the 
corresponding oligonucleotide, and HiPerFect (Qiagen, Cat. No. 301707) added according 
to the manufacturer's instructions. The solution was vortexed for 10 seconds and 
subsequently incubated at room temperature for 10 minutes, prior to drop-wise addition to 
cultures. The cells were harvested 48 hours after transfection, with one quarter from each 
flask used for RT-qPCR analyses of E6, E7, hTERT and p21WAF1/CIP1 mRNA expression, 
and the remaining three-quarters being stored for future Western blot analysis. Cell pellets 
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were washed with DPBS and stored at -80°C until RNA extraction was performed. 
 
2.1.6 RNA extraction and reverse transcription real-time PCR (RT-qPCR) analysis 
Relative quantification of E6, E7, hTERT, and p21WAF1/CIP1 gene expression was 
determined using reverse-transcription quantitative polymerase chain reaction (RT-qPCR). 
Total RNA was extracted from cell pellets using the RNeasy Plus Mini kit (Qiagen, Cat. 
No. 74136), according to the manufacturer’s instructions. RNA quantity and integrity were 
assessed using the Experion Automated Electrophoresis system and RNA StdSens Analysis 
kit (Bio-Rad, Cat. No. 7007013). Reverse transcription into cDNA was done using the 
High-Capacity cDNA Reverse Transcription kit (Fisher Scientific, Cat. No. 4368814). RT-
qPCR reactions consisted of 150 ng of cDNA, 45 µL of TaqMan® Universal PCR Master 
Mix (Thermo Fisher Scientific; Cat. #: 4364338), 4.5 µL of appropriate TaqMan® Gene 
Expression Assay and nuclease-free water for a final volume of 90 µL. Triplicate reaction 
volumes of 25 µL for each sample were loaded into transparent 96-well plates and analyzed 
using a 7500 ABI real-time thermocycler. Hypoxanthine phosphoribosyltransferase 1 
(HPRT1) was chosen as a stable reference gene based on previous experiments (DeCarlo 
et al., 2008). Relative expression was calculated using the 2-ΔΔCT Livak analysis method 
(Livak and Schmittgen, 2001; Bustin et al., 2009). Statistical comparisons were done via a 
one-way ANOVA. 
Table 1. List of qPCR probes used in gene expression analysis. 
Taqman Gene Assay Assay ID 
Full-length HPV16 E6 AI0IW1V (Custom) 







2.1.7 MTT cell viability assay 
 Cell viability was measured via the MTT assay (Mosmann, 1983). Cellular 
metabolic activity is indirectly measured through a colorimetric assay, where tetrazolium 
salts (yellow) are reduced to formazan (purple), in a manner quantitative to cell numbers 
and/or viability. CaSki and SiHa cells were trypsinized and seeded into 24-well plates at 2 
x 104 cells per well. After 24 hours, cells were transfected with 200 µl of complexes using 
HiPerFect chemical transfection reagent following the manufacturer’s instructions. 
Treatments consisted of DsiRNA and C9/11-DsiRNA at concentrations of 2.5, 5, and 10 
nM; with a media-only control. After 48 hours, 25 µL of 5 mg/mL 3-(4,5-Dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT; Sigma-Aldrich, Cat. No. M5655) 
was added to each well and incubated at 37°C for 4 hours. The cell culture media was then 
aspirated, and tetrazolium crystals were solubilized with 100 µL 0.1 N HCl (Sigma Aldrich, 
Cat. No. 320331) in isopropanol (Fisher Scientific, Cat. No. HC5001GAL). Absorbances 
were measured at 570 nm subtracting background at 650 nm using a BioTek® Powerwave 
XS Plate Reader. Each biological replicate (n=4) was performed in technical triplicate. For 
each biological replicate, absorbances amongst technical replicates were averaged, and 
normalized to the average absorbance of the media-only control. Standard deviation was 
calculated across the average relative absorbances. 
 
2.1.8 Cell-cycle and apoptosis assays 
 CaSki and SiHa cells were trypsinized and seeded into 6-well plates at 1 x 105 cells 
per well. After 24 hours, the media was changed, and cells were transfected as described 
previously, with Rosetta DsiRNA or C9/11 DsiRNA at 2.5 nM, 5 nM, and 10 nM. Cultures 
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were treated for 48 and 96 hours. Floating and adherent cells were harvested, pelleting at 
750 rpm for 5 minutes. Cell pellets were resuspended in 5 ml of DPBS and again 
centrifuged for the first wash. Upon resuspension for the second wash, harvested cells were 
divided equally between cell-cycle and apoptosis assays and again pelleted. Cell pellets for 
apoptosis assays were processed immediately for flow cytometry (described below). Cell 
pellets for cell-cycle analysis were fixed by adding 1 ml of 70% ethanol to pellets while 
vortexing (Fisher Scientific, Cat. No. HC11001GL). Fixed cells were stored at 4°C until 
analysis was performed. Data was obtained using a FACSCalibur flow cytometer, utilizing 
BD CellQuest software. 
 Apoptotic assays we performed using an Annexin V FITC Kit (Trevigen, Cat. No. 
4830-01-K), as per kit instructions. During apoptosis, phosphatidyl serine flips to the outer 
membrane of the cell (Fadok et al., 1992), and this phosphatidyl serine can be bound by 
Annexin V in a calcium-dependant manner (Tait and Gibson, 1992). In turn, fluorescently-
tagged Annexin V can be used to label apoptotic cells for flow cytometry analysis 
(Koopman et al., 1994). Briefly, cells were washed with 1X Binding Buffer and 
resuspended in 100 µl of Annexin V Incubation Reagent containing propidium iodide and 
Annexin V-FITC in 1X Binding Buffer. Following a 15-minute incubation, 400 µl of 1X 
Binding Buffer was added and cells were apoptotic events were counted by flow cytometry. 
 For cell-cycle analysis, the fixed cells were removed from 4°C storage and pelleted 
as previous. Ethanol was decanted, and the cells were then washed in 1X PBS and 
resuspended in propidium iodide staining solution (0.1% Triton X-100, 10 µg/mL RNase 
cocktail, 20 µg/mL propidium iodide in 1X PBS). After a 30-minute incubation, cells were 
analyzed by flow cytometry (Shapiro 1988). 
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 Samples were run on a BD FACSCalibur flow cytometer with BD CellQuestTM. 
Software. Events were analyzed using Flowing Software 2, and statistical analysis was 
performed in R version 3.2.3 (R Core Team, 2013) within R Studio (RStudio Team, 2015). 
Samples were prepared for flow cytometry by Peter Villa, with flow analyses and statistical 
analyses performed by PhD candidate Robert Jackson. Software work-flow of apoptosis 
analyses and cell-cycle analyses are illustrated in Figure A1 and Figure A2, respectively. 
 
2.1.9 Cell growth analysis 
 CaSki and SiHa cells were seeded into T-25 flasks at 2 x 105 cells per flask. After 
24 hours, cultures were transfected with DsiRNA complexes prepared using HiPerFect 
chemical transfection reagent according to the manufacturer’s instructions. Cultures were 
treated with Rosetta DsiRNA or the corresponding C9/11 control DsiRNA at a final 
concentration of 10nM. Untreated cultures and cultures treated with the transfection 
reagent only were used as controls. When control cultures reach confluency, all cultures 
for the respective cell type were trypsinized and cell numbers were recorded via a Bio-
Rad® TC10TM Automoated Cell Counter, replating 2 x 105 cells per flask. Cultures were 
transfected 24 hours after each replating, and were subsequently monitored for 17 days. 
Culture doublings were calculated using: 
(number of cells seeded) x 2n = (final cell count) 






2.2 Methods for culturing cervical keratinocytes 
2.2.1 Human research ethics and clinical services 
 This study was approved by the Research Ethics Boards (REB) at Lakehead 
University (#019 16-17) and the Thunder Bay Regional Health Sciences Centre (TBRHSC; 
#2016107), according to Tri-Council Policy Statement 2 (2014) on human research ethics. 
Application to the REB required drafts of the: 1) logistical and laboratory protocols; 2) 
consent form; 3) brief study budget; 4) REB application template, involving risks and 
logistics; and 5) conflicts of interest. Studies must first be registered with the Clinical 
Research Services Department (CRSD) at TBRHSC prior to their application to the REB 
(Figure 5), which meets monthly. This study was registered December 2015, and upon 
submission to the REB at TBRHSC, major revisions were requested in February of 2016. 
The application was re-submitted in March (2016), where minor revisions were requested, 
appended, and approved in April (2016). The application was then sent to Lakehead 
University in May (2016), where minor revisions were again requested and approved by 
June (2016), and subsequently amended at TBRHSC in July of 2016. The project then 
commenced in August of 2016 – over 8 months after registration. 
 For the second phase of this study – which included patient chart review and altered 
laboratory protocols – an amendment was requested in June of 2017, after the study was 
renewed and the summary of the initial results was provided to the REB. This amendment 
was granted through both institutions and the acquisition of samples began again in July of 
2017. 
 Other requests were made through CRSD for additional services. Prior to study 
commencement, CRSD ensured the appropriate training of the affiliated nurses so that they 
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may consent patients to participate in this study. For the second phase of this study, CRSD 
also facilitated a service contract between TBRHRI and TBRHSC-Pathology Services to 
paraffin-embed the 3D raft cultures and prepare slides for immunohistochemistry. 
Pathology Services provided 4 µm Haemotoxylin and Eosin (H&E) stained raft sections 
for this project, as well as additional unstained slides upon request.  
  
 
Figure 5. Schematic representation of the application process for receiving approval 
of a clinical research project. Projects are first registered with the Clinical Research 
Services Department (CRSD) at the Thunder Bay Regional Health Sciences Centre 
(TBRHSC) (1). Applications can then be sent to the Research Ethics Board (REB, 2); 
consisting of literature, scientific merit, laboratory protocols, staff training, and logistics of 
clinical implementation. Once approved, the application is sent to the REB at Lakehead 
University (3). Once approved by both the hospital and university, the study can 
commence. Further services are contracted through CRSD (4).  
 
2.2.2 HPV typing 
 Prior to their colposcopic examination, study participants had a swab of their cervix 
taken, which was to be sent to the Public Health Agency of Canada if they donated a biopsy 
specimen for this study. HPV typing was provided in kind by Dr. Alberto Severini at the 
National Microbiology Laboratory. In brief, a Luminex sequencing platform was used to 
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detect potential HPV type(s) present. HPV DNA was amplified using nested-PCR, and 
probes specific for 45 different mucosal HPV types were used to detect the HPV type(s) 
present (Zubach et al., 2007). This method is capable of detecting multiple HPV types 
present in a single sample. 
 
2.2.3 Culture maintenance 
 Cell cultures were maintained in a humidified incubator at 37°C with 5% CO2. The 
immortalized mouse embryonic fibroblast cell line J2 3T3 (Allen-Hoffmann et al., 2000) 
and primary human foreskin fibroblasts (ATCC, Cat. No. CRL-2097) were cultured in 
Dulbecco's Modified Eagle's Medium (DMEM; Fisher Scientific, Cat. No. SH30243.01) 
containing 10% heat-inactivated fetal bovine serum (FBS; Fisher Scientific, Cat. No. 
SH30396.03) and 1X antibiotic/antimycotic (Fisher Scientific, Cat. No. SV3007901). 
When passaging cultures, cell monolayers were washed with Dulbecco's Phosphate 
Buffered Saline (DPBS; Fisher Scientific, Cat. No. SH30028.02) before adding 2 ml of 
0.05% trypsin containing 0.02% ethylenediaminetetraacetic acid (Trypsin-EDTA; Fisher 
Scientific, Cat. No. SH3023602), and incubated at 37°C for 5-10 minutes until cells were 
sufficiently detached. At which point, 4 ml of culture media was added to inactivate the 
trypsin. Cultures were seeded at 10% confluency and maintained up to 80% confluence 
before subsequent passaging. 
 
2.2.4 Isolation and culture of keratinocytes from cervical biopsy specimens 
 Cultures were established via a modified Liu et al. (2016) method. Biopsy 
specimens were taken by the physician using a Tischler Morgan Biopsy forceps with a 3 
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mm x 7 mm bite (Figure 6). Biopsy specimens were placed in 5 ml of transport media, 
consisting of serum-free DMEM containing 20X antibiotic/antimycotic with 50 µg/ml 
gentamicin (Sigma Aldrich, Cat. No. G1914), and stored at 4°C for several hours until 
processing. Samples were then washed 5 times with 1 ml of DPBS containing 20X 
antibiotic/antimycotic and 50 µg/ml gentamicin. Washed specimens were placed in 1 ml 
of 0.2% Type I Collagenase (Fisher Scientific, Cat. No. 17100017) in 1X Hank's Balanced 
Salt Solution (HBSS; Sigma Aldrich, Cat. No. H4385) containing 3 mM calcium chloride 
and 1mM magnesium chloride, without carbonate. Samples were minced with curved iris 
scissors and incubated on a shaker at 37°C and 225 rpm for 1 hour. Digested specimens 
were washed twice with 10 ml of DPBS, pelleted at 750 rpm for 5 minutes, and re-
suspended in 2 ml of keratinocyte media containing 5% FBS and 1X antibiotic/antimycotic. 
Re-suspended tissue digests were plated onto a collagen- and FBS-coated T-12.5 flask. 
Tissue culture flasks were coated using the Coating Matrix Kit (Fisher Scientific, Cat. No. 
R011K) as per kit instructions, and then coated with 2 ml FBS for 2-3 hours. After 4 to 5 








Figure 6. Tischler Morgan biopsy forceps. Typical forceps utilized by colposcoptists to 
acquire cervical biopsy specimens. Forcep bite of 3 mm wide and 7 mm long. Source: 
https://homeoftech.en.ecplaza.net/products/morgan-tischler-biopsyforceps_2787756 
  
In the first phase of this study ('Phase I'), where methods were developed to culture 
cervical keratinocytes in-house, cervical cells were cultured in Keratinocyte Serum-Free 
Growth Medium (KGM; Cell Applications, Cat. No. 131-500). By contrast, in the second 
phase of this study ('Phase II'), we aimed to increase the in vitro lifespan of keratinocytes 
by replacing the cell culture media with EpiLife basal media (Fisher Scientific, Cat. No. 
MEPI500CA) supplemented with Human Keratinocyte Growth Supplement (Fisher 
Scientific, Cat. No. S0015). Unlike most keratinocyte media, this formulation contains 
recombinant human insulin-like growth factor-I (IGF-I) in place of insulin, which helps to 
reduce differentiation and increase the lifespan of keratinocytes in vitro. IGF-I possesses 
more mitogenic potential than insulin, as it activates more cellular receptors than insulin; 
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where IGF-receptors also interact with intracellular adaptor proteins more effectively than 
insulin receptors (Sasaoka et al., 1996; Figure 7). In turn, IGF-I is 10-50 times more potent 
than insulin at activating MAPK in keratinocytes (Neely et al., 1991), which also has the 
effect of increasing their in vitro lifespan. The basal media also contains a reduced calcium 
concentration to prevent cellular differentiation. In addition, Y-27632 was added to the 
media as a chemical inhibitor of Rho-associated protein kinase (ROCK). This drug has 
been shown to drastically increase the lifepsan of keratinocytes in vitro (Strudwick et al., 
2015). Inhibition of ROCK reduces expression of down-stream targets for p53, which is 
thought to be a major mechanism by which Y-27632 promotes longevity. As well, ROCK-
inhibition has been shown to synergize with E6, and promote drug-dependant cellular 
immortalization of keratinocytes without the need for E7 (Dacik et al., 2016). 
 Once cultures were established, keratinocytes were maintained at 10% to 80% 
confluence between passages. Cultures were split using 2 ml of Trypsin-EDTA, whereby 
trypsin was inhibited with 3 ml of Trypsin Neutralizing Solution (Cell Applications, Cat. 
No. 080-100). The cells were centrifuged at 750 rpm for 5 minutes, where the neutralized 
trypsin solution was removed, and cells were re-suspended in fresh cell culture media (i.e. 
KGM or EpiLife with Y-27632, for Phase I and Phase II, respectively). Cells were counted 
using a BioRad TC-10TM Automated Cell Counter. New flasks were coated with collagen 






Figure 7. Signalling pathway of Insulin and Insulin-like Growth Factors. Insulin-like 
Growth Factors (IGFs) possess greater mitogenic potential than Insulin signalling, where 
IGF-receptors interact with Shc/Grb2/Sos more effectively than insulin-receptors (Sasaoka 
et al., 1996), and activate MAPK in keratinocytes with greater potency than insulin (Neely 




2.2.5 Mycoplasma testing 
 Primary cell cultures were tested for Mycoplasma indirectly by using the J2 3T3 
fibroblast cell line as an indicator cell line. In this method, the J2 cells are cultured in media 
from the cell line in question (i.e. the primary cervical cells), in order to infect the indicator 
cell line. It is commonly observed that Mycoplasma replicate at a much lower rate and at 
lower titres in primary cells, which may cause ambiguous or delayed results when trying 
to observe Mycoplasma directly within the cell's cytoplasm. Therefore, an indicator cell 
line that is highly permissive to Mycoplasma infection and replication is utilized, such as 
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the J2 cell line (McGarrity and Barile, 1983). These J2 cells were cultured in conditioned 
media from cervical cell cultures were tested for Mycoplamsa contamination by fluorescent 
staining with 4'-6-diamidino-2-phenylindole (DAPI). This method stains the DNA of 
Mycoplasma thereby permitting their visualization within the cytoplasm of infected cells 
via fluorescent microscopy. Approximately 1 x 104 J2 cells were seeded onto sterile glass 
cover slips (Thermo Fisher Scientific, Cat. No. 12-541A) and grown in 35mm cultures 
dishes in 3 ml of media consisting of 2 ml DMEM-FBS with antibiotic/antimycotic, and 1 
ml of conditioned media. After 3 days, the media was removed and cells were fixed using 
Carnoy's fixative [3:1 solution of methanol (Thermo Fisher Scientific, Cat. No. A4544) 
and glacial acetic acid (Sigma-Aldrich, Cat. No. 695092-2.5L), respectively]. Fixative was 
first added to cells for 5 minutes, whereby the fixative was then removed, and fresh fixative 
was added for another 10 minutes. The cover slips were then removed and allowed to dry. 
Cover slips were then mounted on a microscope slide using Vectashield Mounting Medium 
containing DAPI (1.5 µg/mL, Vector Laboratories. Cat. No. H-1200).  
 
2.2.6 Construction of organotypic raft cultures 
 Early passage primary human foreskin fibroblasts were cultured as described 
previously, and low passage (P<5) human fibroblasts were used in the preparation of 
dermal equivalents. Fibroblasts were trypsinized and counted, and 1 x 106 cells were 
pelleted and re-suspended in 2 ml FBS. Using a sterile 50 ml beaker with a magnetic stir 
bar, cooled in ice atop a magnetic stir plate, 7.5 ml of type I rat tail collagen (~4.00 mg/mL; 
Millipore, Cat. No. 08-115) and 1 ml of 10X HBSS was added and thoroughly mixed. The 
solution was neutralized using 5 µl increments of 5 N NaOH, requiring ~30 µl in total. 
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Once neutralized, the fibroblasts were immediately added and thoroughly mixed. Dermal 
equivalents were then prepared by pipetting 500 µl of the collagen-cell suspension into 
wells of a 48-well plate (yielding ~5 x 105 fibroblasts per dermal equivalent). The dermal 
equivalents were then incubated for ~30 minutes at 37°C, where they would solidify. 
Afterwards, 500 µl of DMEM-FBS was added to the top of each raft and incubated 
overnight. 
 Rafts were prepared in technical triplicate for each patient culture. For each raft, 
2.5 x 105 keratinocytes were needed to create the basal layer of the epidermis. 
Keratinocytes were trypsinized and re-suspended to yield 5 x 106 cells/ml, so that the 
desired cell number could be seeded on top of rafts in a 50 µl cell suspension. Keratinocytes 
were re-suspended in media consisting of equal parts EpiLife Media and NIKS Complete 
Media. NIKS Complete media was prepared containing 3 parts Ham's F-12 media 
(Invitrogen, Cat. No. 21700-075) to 1 part DMEM; supplemented with 2.5% FBS, 0.4 
µg/mL hydrocortisone (Sigma-Aldrich, Cat. No. H4001), 8.4 ng/mL cholera toxin (Sigma-
Aldrich, Cat. No. C8052), 5 µg/mL insulin (Sigma-Aldrich, Cat. No. I5500), 24 µg/mL 
adenine (Sigma-Aldrich, Cat. No. A2786), and 10 ng/mL epidermal growth factor (EGF; 
R&D Systems, Cat. No. 236-EG). Media was removed from the dermal equivalents and 
the 50 µl of keratinocyte cell suspension was added to the top of each raft. The rafts were 
placed in the incubator for 2 hours, allowing the keratinocytes to adhere. Afterwards, 500 
µl of the 50/50 EpiLife/NIKS Complete media was added to each raft, and incubated for 
two days. This protocol typically calls for the use of NIKS Complete medium, however, 
we decided to partially supplement with EpiLife medium. This is because EpiLife contains 
IGF-I which is the major mediator for dermal invasion from permissive keratinocytes 
33 
 
(Pickard et al., 2015). Therefore, we hypothesized that the presence of IGF-I during this 
growth phase may facilitate dermal invasion, if the keratinocytes were isolated from a high-
grade or cancer lesion. 
 After incubating the submerged keratinocytes on the dermal equivalents for two 
days, the media was removed and rafts were lifted to an air-liquid interface. A micro spoon 
was used to transfer the rafts from the 48-well plate onto Millicell 30 mm, 0.4 µm inserts 
(Millipore, Cat. No. PICMORG50) placed in 6-well plates, where 1.1 ml of FAD media 
was added around each insert, at one insert per well. FAD medium consists of NIKS 
Complete medium without EGF, and with the addition of Ca++ to 1.88 mM, which 
facilitates differentiation of keratinocytes. The FAD media was replaced every 2 days, 
where residual media that accumulated around the rafts on top of well-insert membrane 
was removed. After 14 days, rafts were fixed overnight in 10% buffered formalin (Fisher 
Scientific, Cat. No. SF100-4). The rafts were subsequently washed once and stored in 70% 
denatured ethanol (Fisher Scientific, Cat. No. HC11001GL). Formalin-fixed rafts were 
then sent to Pathology Services at TBRHSC for paraffin-embedding, and preparation of 4 
µm thick H&E slides. 
When troubleshooting patient-raft cultures that had minimal stratification, we 
decided to utilize EpiLife media as the basal component to the differentiation media. We 
hypothesized that cultures were acclimated to the rich formula and possessed reduced 
proliferation when switched to FAD media. Therefore, in a subsequent trial we 
supplemented EpiLife with 10 ng/ml EGF, 8.4 ng/ml cholera toxin, and 2.5% FBS to 
simulate NIKS medium when seeding keratinocytes onto dermal equivalents (termed 
EpiLife-NIKS). After lifting raft cultures, we used an FAD-style supplemented EpiLife 
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medium for differentiation, whereby Ca++ was added to a final concentration of 1.88 mM, 
with 2.5% FBS and 8.4 ng/ml cholera toxin (termed EpiLife-FAD). Note that we did not 
further supplement EpiLife with hydrocortisone or adenine, as these are already present in 
HKGS-supplemented EpiLife, nor did we add insulin as HKGS contains IGF-I in place of 
insulin. We compared the use of NIKS medium and EpiLife-NIKS, and changed the media 
to FAD and EpiLife-FAD, respectively, after lifting rafts. We also tested whether wetting 
the raft during media changes would affect the stratification, as this is recommended in 
some commercial protocols. Each condition was replicated in triplicate for comparison. 
 
2.2.7 Microscopy 
 Cells were visualized using an Axiovert 200 Inverted Microscope manufactured in 
Germany, with HBO 50 Watt AC-L2 mercury bulb connected to a MBQ 52 AC power 
supply. Images were taken using a QICAM 12-bit FAST 1394 camera. All phase-contrast 
images were taken at 200X magnification. For mycoplasma testing, a 350 nm blue emission 
filter was used. 
 Histology images were taken using a Zeiss Axioskop 50 manufactured in Germany, 











3.1 Results from E6 knock-down on downstream processes 
3.1.1 Expression levels of E7 and hTERT 
In previous work, cultures of CaSki and SiHa were transfected in T-25 flasks as 
described, and both Western blot and RT-qPCR analysis was performed (Figure 4). We 
sought to utilize these same cDNA samples to analyze downstream effects of E6 knock-
down. Analysis of E7 expression revealed a large variability in CaSki cells as compared to 
SiHa cells. There was no change in E7 expression for CaSki cells, as the average fold 
change was close to 1 for all Rosetta and Scrambled treatments (Figure 8). SiHa cells 
showed markedly decreased expression of E7 for most treatments regardless of DsiRNA 
type. Expression of hTERT was also more variable for CaSki than SiHa cells. The 
expression of hTERT was not significantly different between Rosetta and Scrambled 






Figure 8. Relative expression of E7 and hTERT 48 hours after E6 knock-down. 
Expression levels were determined relative to HPRT-1. Treatments were normalized to the 
media-only control, where a fold-change of ‘1’ indicates no change. No significant 
difference was found between Rosetta and Scrambled DsiRNA treatment. Data represents 






3.1.2 Validation of C9/11 control DsiRNA 
 For further downstream analysis, we intended to replace the Scrambled DsiRNA 
control with the C9/11 DsiRNA control. By doing so, off-target effects of the Rosetta 
DsiRNA oligonucleotide can be maintained, while E6 knock-down is abolished. Cultures 
were treated with the C9/11 DsiRNA as described, and RT-qPCR analysis indicated no 
significant difference in E6 fold-change relative to media-only condition (Figure 9). 
Levels of E6 expression were higher than the media-only condition for all C9/11 treatments 
in both CaSki and SiHa cells, although this was not significant. Therefore, we continued to 
utilize the C9/11 DsiRNA control when using Rosetta DsiRNA for E6 knock-down.  
 
 
Figure 9. Relative expression of E6 48 hours after treatment with C9/11 DsiRNA. 
Expression levels were determined relative to HPRT-1. Treatments were normalized to the 
media-only control. No significant difference was found between C9/11 and media-only 







3.1.3 Analysis of p21WAF1/CIP1 expression 
Previous Western blot data has demonstrated a recovery in p53 levels upon E6 
knock-down, though this data was not statistically significant. The expression levels of 
p21WAF1/CIP1 were quantified to support whether the restored p53 was transcriptionally 
active. Levels of p21WAF1/CIP1 were detected but not quantifiable in SiHa cells (data not 
shown). Data from the CaSki cells revealed no significant increase in p21WAF1/CIP1, nor any 
general trend (Figure 10).  
 
 
Figure 10. Expression of p21WAF1/CIP1 in CaSki cells following E6 knock-down. 
Expression levels were determined relative to HPRT-1. Treatments were normalized to the 
media-only control. Previous work had demonstrated variable and non-significant p53 
restoration upon E6 knock-down. The levels of p21WAF1/CIP1 were undetectable in SiHa 
cells. Data represents the mean ± SD (n=3). 
 
3.1.4 MTT viability assay following E6 knock-down 
 MTT assays were performed on transfected cultures of CaSki and SiHa cells to 
assess changes in viability. In this respect, decreases in cell growth and/or increases in cell 
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death can be inferred from overall changes in viability. There was no significant difference 
between Rosetta DsiRNA treatment versus the C9/11 control (Figure 11).  
 
 
Figure 11. MTT viability assay of CaSki and SiHa cells transfected with DsiRNA. 
Cultures were seeded into 24-well plates and transfected with either Rosetta DsiRNA or 
C9/11 DsiRNA. The colorimetric assay was performed 48 hours later and absorbance was 
measured at 570 nm subtracting the background at 650 nm. There was no significant 
difference between Rosetta and DsiRNA treatment. Data represents the mean ± SD (n=4). 
 
3.1.5 Cell-cycle and apoptosis assays 
 Although no significant changes in cell viability were detected by the MTT assay, 
we sought to perform more sensitive experiments to assess apoptotic events and possible 
changes in cell-cycle. Additionally, we assessed cultures at both 48 and 96 hours after 
transfection. Transfected cultures were split equally between apoptosis assays and cell-
cycle analysis. Full cell-cycle results are shown in Figures A3 and A4. There were no 
significant differences between Rosetta and C9/11 treatments. In a subsequent analysis, a 
G1:S ratio was calculated to suggest whether or not cells were slowly accumulating in an 
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arrested state. A significant difference (P<0.05) was found between Rosetta DsiRNA and 
C9/11 control for CaSki 48 hours after treatment (Figure 12).  
 
 
Figure 12. G1:S ratio of CaSki and SiHa cells 48 hours after treatment with DsiRNA. 
The ratio of cell populations in the G1 phase versus S phase show a statistical difference 
between Rosetta and Control DsiRNA (P<0.05) at 5 nM and 10 nM Rosetta DsiRNA for 
CaSki. No statistical difference was found for CaSki at 96 hours, or SiHa at 48 and 96 
hours (data not shown). Data represents the mean ± SD (n=3). 
 
 When assessing apoptotic events, there were no significant differences between 
Rosetta and C9/11 DsiRNA treatments for early, late, and total apoptotic events, at 48 or 
96 hours, for either cell type. Data are illustrated in Figures A5-A8. 
 
3.1.6 Cell growth analysis 
 To assess changes in cell growth over a longer period, we transfected cultures 
periodically over several passages to observe changes in proliferation. This longer time 
interval can illustrate more minute changes that the previous assays cannot. This 
experiment was done in a single replicate (Figure 13). The growth curve suggests that the 





Figure 13. Growth curve of CaSki and SiHa cells transfected periodically with 
DsiRNA. Cultures were transfected 24 hours after passaging. Transfection days are 
illustrated by a vertical dotted line. Cultures were transfected with 10 nM of Rosetta 
DsiRNA or C9/11 control (n=1). 
 
3.2 Results from creating patient-derived cervical keratinocyte cell cultures 
3.2.1 Phase I - methods for isolating and propagating cervical keratinocytes 
 Thirty biopsy specimens were acquired over a 7-month interval, from August 2016 
to March 2017. The Stanley (2002) method was used on the first 5 biopsies to validate our 
ability to process biopsy specimens. These samples however, yielded only sparse fibroblast 
42 
 
colonies. The modified Liu et al. (2016) method was used on the other 25 biopsy 
specimens. Initially, when colonies were established 4 or 5 days after biopsy processing, 
the media was switched to KGM containing 0.5% FBS. This resulted in significant 
fibroblast growth by the second or third week (Figure 14). Upon passaging one of these 
cultures, the cells adhered and slowly lifted over the course of 5 days, where the presence 
of serum was suspected to be a factor. Therefore, there were a total of 6 biopsies between 
the Stanley method and presence of serum for which a culture lifespan could not be 
determined. Of the remaining 24 biopsies acquired, the media was switched to serum-free 
KGM, instead of KGM-0.5% FBS, once the cell colonies were established following 
biopsy processing. Some of these cultures differentiated before passaging (n=4), whereas 
others were successfully passaged and continued to grow before differentiating (n=3). 
When using serum-free KGM, there were no further instances of keratinocytes lifting from 
the culture flasks, nor was there sustained fibroblast growth. 
 
Figure 14. Fibroblast contamination from cultures containing 0.5% fetal bovine 
serum in Keratinocyte Growth Medium. Fibroblast colony present at Day 15 in patient 
culture #44 (A). Fibroblast growth present near a proliferating keratinocyte colony at Day 
21 in patient culture #13 (B). Fibroblasts were identified by morphology. Scale bars 
represent 200 microns. 
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 Biopsy specimens varied considerably in size. The smallest specimens (6/25) were 
approximately 1 mm in all dimensions, and were too small to be minced with the curved 
iris scissors. The largest specimens (8/25) were roughly a uniform 4 mm across. Most of 
the specimens (11/25) were between these sizes, and were typically 2-3 mm wide and ~1-
2 mm in height and depth. This likely reflects the bite of the Tischler Morgan 3 mm x 7 
mm biopsy forceps, where the size varied by the ability of the physician to precisely sample 
the lesion. In turn, the smallest biopsy specimens would be from the very edge of a lesion 
(as the first and better biopsy taken was used for standard-of-care). There were notable 
differences in the ability to establish proliferative cultures from the various biopsy sizes 
(Table 2). The ability to establish cultures from biopsy specimens correlated with size. 
 
Table 2. Successful establishment of keratinocyte cultures from cervical biopsies. 
Larger biopsy specimens had a higher probability of producing proliferative cultures. Note 
that of 30 specimens acquired, 5 were used with the Stanley (2002) method and are not 
included in this chart. Nearly half of all specimens that yielded colonies did not proliferate 
(6 out of 14 total). Small biopsies typically represent those that were 1 mm x 1 mm x 2 mm 
or smaller, whereas large biopsies were uniform 3-4 mm specimens, and medium biopsies 













Small 6 2 0  0% 
Medium 11 4 2 18% 
Large 8 0 6 75% 
 
 Differentiation was evident upon microscopic examination, as cultures would 
exhibit noticeably reduced growth (i.e. modest changes in confluency over the course of 
one week). Cells would then cease to proliferate and markedly increase in cross-sectional 
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area for approximately one or two more weeks (Figure 15). Therefore, lifespan was 
estimated retrospectively from the dates by which cells dramatically increased in size and 
had previously shown decreased proliferation. The median time to differentiation was 4 
weeks. Culture lifespan from actively proliferating cultures is depicted in Figure 16. A 
slight heterogeneity existed between proliferating and differentiated cultures between 
patients, as exemplified in Figure 17. Mainly, cultures may differentiate at varying sizes, 
though they still exhibited uniformly flattened keratinocytes with centred nuclei.  
 
Figure 15. Visible and progressive differentiation of keratinocytes from patient isolate 
#22. Keratinocytes are visibly proliferating up to Day 21 (A). Keratinocytes have modestly 
but homogeneously increased in their apparent size by Day 26 (B). Keratinocytes are no 
longer proliferating, cell nuclei become centred, and cell membrane begins to spread along 
the flask evenly around the cell by Day 34 (C). Cells have uniformly increased in size by 










Figure 16. Differentiation plot of keratinocytes grown from cervical biopsy specimens 
in vitro. Cultures were established from 7 of 24 biopsy specimens. The median 
proliferating culture established would differentiate by the fourth week. Image was 











Figure 17. Modest variations between patients in phenotype of proliferating and 
differentiated keratinocytes. Cultures from patients #13 and #67 appear very similar in 
morphology between their respective proliferating and differentiated cultures. Proliferating 
keratinocytes in culture #96 appear normal, however the differentiated keratinocytes 






 Although the doubling time could not be accurately measured for most cultures, the 
approximate rate-of-change in confluency between cultures seemed to be similar, with an 
approximate doubling time between 2 and 3 days. This metric however, does not reflect 
the total number of cells that initiated the culture, and therefore does not reflect the total 
yield of cells acquired in vitro. A summary of biopsy metrics and final flask size is 
summarized in Table 3. Under these conditions, culture lifespan was the largest contributor 
to cell yield. Images of representative biopsy sizes are shown in Figure 18. 
 
Table 3. Summary of biopsy specimen metrics on size, lifespan, and total relative cell 
yield. Cultures were progressively scaled from T-12.5 flasks, to T-25 flasks, and 
subsequently T-75 flasks where they were maintained. Median culture lifespan was 4 
weeks. 
Patient Number Biopsy Size Culture Lifespan 
(Weeks) 
Order of Flask Size 
at Differentiation 
13 Large 4 T-25 
17 Large 4 T-12.5 
22 Medium 4 T-25 
28 Medium 8 T-75* 
59 Large 3 T-12.5 
67 Large 5 T-25 
96 Large 7 T-75* 
*Cultures were passaged once from the first T-75 flask but differentiated shortly thereafter, 




Figure 18. Images of biopsy specimens illustrating variations in size. Sizes of 
specimens differed markedly between patients, from small specimens ~ 1 mm x 1 mm x 1 
mm (A), medium specimens ~ 2 mm x 2 mm x 3 mm (B), and large specimens ~ 3 mm x 
3mm x 3mm (C).  
 
3.2.2 Phase II – increasing in vitro lifespan of cultures and organotypic raft construction 
 The cell culture media was switched from KGM to EpiLife media containing 
Human Keratinocyte Growth Supplement, as this formulation is rated to produce over 
twice as many population doublings (Li S et al., Cascade Biologics Inc). This increase in 
lifespan is attributed to the decreased Ca++ concentration, the presence of IGF-I instead of 
insulin, and an increase in the number organic components and inorganic salts. In addition, 
once cultures had been established from processed biopsies in the presence of 5% FBS, the 
media was switched to serum-free fully-supplemented EpiLife containing the ROCK 
inhibitor Y-27632, which inhibits differentiation of epithelial cells, increasing lifespan and 
potentially promoting immortalization (see 'Materials and Methods'). 
 Additional patient information was collected for the second phase of this study. 
Patients had their cervix swabbed for HPV typing, and their age and lesion grade was 
recorded. From the first phase of the study, it was also observed that some biopsy 
specimens would digest well with collagenase – where minced tissue fragments would 
digest into a visibly turbid cell suspension, and residual extracellular matrix would expand 
49 
 
and clump – while others would not digest at all with collagenase. This observation 
appeared to be correlated with establishing colonies and therefore, in the second phase it 
was noted whether each biopsy digested well or poorly as an additional parameter. Overall 
observations and results for establishing cultures are illustrated in Table 4. Interestingly, 
under these modified culture conditions, all instances where colonies were established from 
specimens yielded sustained cell growth. Cultures were established from 6 of 14 biopsy 
specimens (~43% efficiency). The average specimen in Phase II was also notably smaller 
than those in Phase I of this study. As biopsy size was correlated with efficiency in Phase 
I, this observation may suggest that our overall efficiency in establishing a proliferating 
culture was markedly improved by these new culture conditions. 
 There were two patient cultures that survived long enough to test cryogenic storage 
and have their doubling times accurately calculated via cell counts when passaging 
cultures. Cultures 3UI and AV6 both survived storage in liquid nitrogen with high re-
adherence rates. Culture 3UI possessed a doubling time of ~30 hours, and culture AV6 
possessed a doubling time of ~24 hours. The median culture lifespan in the second phase 
of this study was 4.5 weeks. Therefore, our modifications to the cell culture media have 












Table 4. Summary of biopsy parameters, patient information, and culture growth. 
Biopsy size and visible digestion were noted on the day of sample processing. Patient's 
age, HPV type(s), and lesion grade were recorded. Culture lifespan was measured as 
previous, to time of differentiation. Cultures were established in T-12.5 flasks and scaled 
up T-25 flasks, then to T-75 flasks before consecutive passaging in T-75 flasks, were each 












Lifespan (weeks) / Flask 
Scaling & Passage 
M33 Medium Poor 56 39 * - 
UB1 Small Poor 27 45,59 I - 
8N8 Small Poor 24 16 III - 
QA7 Small Poor 35 45 Neg. - 
A1U Large Good 25 6 I 5 / T-75 (P2) 
LY2 Medium Poor 23 53,66 I - 
HL7 Medium Poor 29 45 III - 
IW9 Small Good 32 16 II-III 5 / T-75 (P2) 
78I Small Poor 22 52,82,89 Neg. 4 / T-25 
V7V Small Poor 69 16,90 Neg. - 
3UI Medium Good 36 31,45,89 II 6 / T-75 (P7) 
04P Medium Good 23 51,54,81 I 4 / T-25 
R41 Small Poor 54 58 Neg. - 
AV6 Medium Good 27 16 II 4 / T-75 (P6) 
*Patient presented with metaplasia 
 
 
 When assessing the parameters of successfully established cultures, several trends 
emerge. Firstly, most patients are in their mid-twenties to mid-thirties, which is a narrow 
range for identifying correlations with age. Secondly, there was no obvious correlation with 
lesion grade or the presence of high-risk HPV types in an established culture: only 1 of 3 
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CIN III lesions were successfully cultured, and only 3 of 8 specimens that contained high-
risk HPVs (i.e. 16, 18, 31, and/or 45) were successfully cultured; while 2 of 4 CIN I lesions, 
and 1 of 4 CIN negative lesions were successfully cultured. The two cultures that were 
passaged the longest were isolated from CIN II lesions, suggesting that lesion grade also 
does not predict in vitro proliferative capacity. These parameters however, may be masked 
by the importance of biopsy size, or other parameters. Only 2 of 7 small biopsies yielded 
cultures, while 3 of 6 medium and 1 of 1 large biopsies yielded cultures. The first phase of 
this study, which showed biopsy size was the biggest correlate; had fewer small biopsies. 
Lastly, tissue digestion and visible turbidity appeared to be strongest correlate in ‘Phase 
II’, where 5 of 5 well-digested biopsies yielded cultures, and only 1 of 9 poorly digested 
samples yielded a proliferating culture. 
 For all proliferating cultures, we intended to generate organotypic raft cultures in 
triplicate as soon as reasonably possible, given that we did not know when cultures would 
reach their lifespan, or whether they would survive cryogenic storage in liquid nitrogen. 
This meant generating rafts from near-confluent T-25 flasks, or sufficiently confluent T-
75 flasks. All of these cultures were tested for Mycoplasma indirectly using the J2 
fibroblast cell line as an indicator. All cultures tested negative for Mycoplasma under these 





Figure 19. Fluorescent images of DAPI-stained J2 fibroblasts treated with 
conditioned media from patient-derived keratinocyte cultures. Fibroblasts were grown 
in the presence of conditioned media for 3 days. Images showing samples 3UI (A), 04P 





 When seeding keratinocytes onto dermal equivalents, the relative size of the 
keratinocytes was noted from the TC-10TM Cell Counter. Typically, keratinocytes from 
patients or commercial sources were homogeneously between 16 and 18 µm in diameter 
while actively proliferating. When cells were beginning to differentiate, a discrete 
proportion of the population would exist between 22 to 24 µm. For example, when 30-50% 
of the cells were 22-24 µm, the culture would differentiate on the current passage when re-
seeded. This observation held true for all cultures in the second phase. The proportion of 
small-to-large cells was recorded upon passaging to note when cultures would differentiate. 
At the time of raft culture, it was noted for patient cultures A1U, IW9, and 78I, that one-
third of the population existed at 22-24 µm, and 04P was one-half 22-24 µm; illustrating 
that these cultures were near their in vitro lifespan at the time they were seeded onto dermal 
equivalents. Indeed, the remaining cell suspension (i.e. in excess from seeding for raft 
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cultures) were re-seeded back into monolayer culture, and differentiated without further 
passaging. Culture 3UI was the only sample that was homogeneously small (i.e. 16-18 µm) 
at the time of 3D culturing. 
 Raft cultures were created in technical triplicates when keratinocyte numbers 
permitted (i.e. A1U, 04P, 3UI, IW9) and duplicate when cell numbers were limiting (i.e. 
78I). We proceeded with raft culturing as described (see ‘2.2.6 Construction of organotypic 
raft cultures’), and cultures were maintained at the air-liquid interface for 14 days. Raft 
cultures were then formalin-fixed and sent to Pathology Services at TBRHSC for paraffin-
embedding, slide preparation, and H&E staining. The resulting representative H&E images 
are illustrated in Figure 20. From the representative images, it appeared that much of the 
epidermis was sloughed off during processing. Similarly, as all of the samples – other than 
3UI – grew rather poorly, it seems these 3D cultures were significantly affected by the fact 
that the keratinocytes had nearly reached their in vitro lifespan. Interestingly, although IW9 
did not yield much epidermis, regions that were akin to epithelial invasion of the dermis 
were visible in all technical replicates (Figure 21). These events were not evident in any 







Figure 20. H&E images of organotypic raft cultures grown using patient-derived 
cervical keratinocytes. Dermal equivalents were prepared with type-IV rat tail collagen 
and human neonatal foreskin fibroblasts. After 24 hours, keratinocytes were seeded on top 
and incubated for 2 days. The rafts cultures were then lifted and cultured at air-liquid 
interface for 14 days before formalin fixation. Formalin-fixed raft cultures were paraffin-
embedded and 4 µm sections were prepared for H&E staining. Stained sections did not 






Figure 21. Organotypic raft culture using IW9 keratinocytes showing possible 
invasion events. Keratinocyte culture IW9 is derived from a CIN II-III lesion that tested 
positive for HPV 16. Possible instances of keratinocyte invasion of the dermis are indicated 
by red arrows. This possible invasion was evident in all technical replicates (A, B, and C). 
Scale bars represent 100 microns. 
 
Given that 3UI appeared to be the most successful 3D culture, even though it still 
experienced significant dermal detachment and poor keratinocyte growth around most of 
the raft, we questioned whether altering the media formulation or rafting conditions could 
improve epithelial growth. As EpiLife is a richer medium than FAD, we reasoned that 
keratinocytes may have a reduced growth rate when switched to FAD medium. Therefore, 
EpiLife media was prepared with the differentiation components of FAD media, in the 
hope that this richer formulation would sustain keratinocyte growth. Additionally, some 
protocols call for 'raft-wetting' where the rafts are periodically wet with media to simulate 
the wetting of the mucosa. Twelve rafts were prepared using 3UI: six with FAD media and 
six with EpiLife-Differentiation media, 3 with wetting and 3 without wetting for each 
media. All four conditions yielded similar results (Figure 22), with limited epithelial 
growth. Notably, these rafts yielded less epithelial growth than previously created rafts. 
The cells used in this trial were of two passages higher and had been retrieved from 




Figure 22. H&E images of organotypic raft cultures of 3UI. Organotypic rafts were 
created in triplicate using FAD media with (A) and without wetting (B) rafts with media, 
as well as EpiLife formulated to simulate FAD with (C) and without (D) wetting. Scale bar 
represents 200 microns. 
 
4. Discussion 
4.1 Downstream effects of E6 knock-down 
In this study, we found minimal downstream effects resulting from E6 knock-down 
on the cell lines CaSki and SiHa, even though our level of knock-down similar to literature 
(Jiang and Milner, 2002; Leitz et al., 2014; Khairuddin et al., 2014). Given that p53 
restoration had been shown to be quite variable, it is unsurprising that p21WAF1/CIP1 levels 
are unrestored, or that there are no measurable changes in apoptosis.  
Importantly, targeting the E6 splice site with RNAi seemed to preserve E7 
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expression as hoped, substantiating the rational design of this oligonucleotide. 
Interestingly, even though E6 levels were measurably decreased, there was no reduction in 
hTERT levels. It may be that hTERT levels would decrease at a different time point, or 
that only low levels of E6 are required to saturate hTERT transcription. 
It is unclear why these cell lines seem to respond poorly to RNAi. It may be that 
these cell lines have adapted to their in vitro culture conditions since their founding (Friedl 
et al., 1970; Pattillo et al., 1977), perhaps undergoing epigenetic or karyotypic changes that 
have selected for quickly diving cells in vitro. For these reasons, there are significant merits 
to developing new patient-derived cell lines. 
 
4.2 Processing biopsy specimens 
 In this study, we utilized a slightly modified version of the Liu et al. (2016) method 
to process biopsy specimens. Briefly, after coating tissue culture flasks with type I 
collagen, we added pure FBS to the coating in the hopes that growth factors, cell adhesion 
molecules, or other signalling and mitogenic factors from the serum would adhere to the 
collagen-coating, and thus the tissue culture flask. These factors in turn, would help 
mediate the adaptation of cells to monolayer culture, after being liberated from biopsy 
specimens. In Liu et al. (2013) it was found that the presence of serum in the media greatly 
increased the adhesion of tissue-liberated keratinocytes to the culture flask, with or without 
the presence of a collagen coating. We also reasoned that since the explant methodology 
of Stanley (2002) minces tissue fragments and adheres them to culture flasks in pure FBS, 
that FBS itself may act as a flask coating and facilitate the adaptation of cells to monolayer 
culture. During the course of experimentation, it was noted that while most of the colonies 
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established from processed biopsies existed as monolayer cells, some colonies were 
initiated as tissue fragments fused to the culture flask (Figure A9). This indicates that 
although digestion with collagenase does liberate individual cells, it also facilitates the 
transfer of these 'micro' explant fragments into culture. Thus, minced biopsy specimens 
that are subsequently digested with collagenase should not be treated as single-cell 
suspensions, as this may contribute to cell losses. 
 One hurdle in the establishment of monolayer cultures from epithelial biopsy 
specimens is the significant potential for microbial contamination. The Liu et al. (2013) 
method did not indicate the number of hysterectomies acquired, nor whether any of the 
cultures were contaminated once cultures were established. The Liu et al. (2016) study 
however, acquired only six biopsy specimens total, and indicated no instances of 
contamination. For the vaginal and oral tract, the most significant sources of contamination 
are yeast, Gram negative bacteria, and potentially Mycoplasma (Stanley, 2002). Indeed, 
Schweinfurth et al. (2006) reported that bacterial overgrowth was a significant hurdle in 
their initial protocol to establish epithelial cell cultures from upper respiratory epithelium, 
though the details surrounding this contamination are not indicated. Interestingly, 
Rheinwald and Beckett (1981) acquired 22 biopsy specimens from the tongue and pharynx 
of different patients, where 7 became contaminated with yeast despite the fact that 
specimens were transported and rinsed with media containing amphotericin b 
(concentration not indicated) – the main antifungal agent used in tissue culture. Stanley 
(2002) recommends using amphotericin b at concentrations of 5-10 µg/ml for transport 
media and buffered saline washes, which was also reported as the method in Liu et al. 
(2013). We utilized amphotericin b at a concentration of 5 µg/ml in both the transport 
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media and DPBS washes of specimens, and experienced no instances of yeast 
contamination. Amphotericin b interacts with ergosterol in the membrane of fungi, forming 
a channel for monovalent ions. This altered membrane permeability leads to cell death, but 
in the presence of ideal carbon sources and sufficient nutrients, fungi – yeast in particular 
– can counteract the effects of lower amphotericin b concentrations (Bolard et al., 1993). 
We used 20X antibiotic/antimycotic specifically to reach the concentration of 5 µg/ml; and 
as this also yielded a penicillin concentration of 2,500 units/ml and a streptomycin 
concentration of 2.5 mg/ml, we had no instances of bacterial growth. Unfortunately, none 
of these publications reported the Mycoplasma status of established cultures. Mycoplasma 
is inherently resistant to penicillin antibiotics as they possess no peptidoglycan cell wall, 
but some species are susceptible to streptomycin as it binds to the 30S ribosomal subunit 
thereby inhibiting protein translation. We chose to add gentamicin to transport media and 
DPBS washes, which also interacts with the 30S ribosomal subunit, but has a more broad-
spectrum activity against Mycoplasma than streptomycin (Taylor-Robinson and Bebear 
1997), has a stronger bactericidal (as opposed to bacteriostatic) activity, and possesses a 
lower effective concentration than streptomycin in cell culture (Fischer, 1975). Though we 
did not test cultures for Mycoplasma in 'Phase I' of this study, we found no evidence of 
Mycoplasma contamination when testing the established keratinocyte cultures from 'Phase 
II'. Therefore, it would seem our antimicrobial cocktails and experimental protocols have 
avoided contamination issues that were present in many other studies. 
 
4.3 Efficiency in establishing cell cultures, and culture lifespan 
 In 'Phase I' of this study, we aimed to employ our slightly modified Liu et al. (2016) 
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method to evaluate the efficiency of establishing keratinocyte cultures from biopsy 
specimens, and to assess their in vitro lifespan. The aim of this study was to determine 
whether we could establish cultures frequently enough and with a sufficient lifespan for 
further downstream experimentation (e.g. Western blot analysis, RNA extraction and 
qPCR, organotypic raft cultures, etc.). Interestingly, our results were nearly identical to 
Schweinfurth et al. (2006) who reported an efficiency of ~32% (n=7 of 22 biopsies) 
compared to our ~32% (n=8 of 25), and reported an average lifespan of 30 days in culture, 
compared to our 4 weeks. Additionally, their longest culture lasted 60 days, whereas ours 
grew for 8 weeks. Despite this similarity, it is important to note that these metrics do not 
truly reflect the overall population doublings in either case, and this result is only 
comparable if the doubling time is similar between our cultures and those of Schweinfurth 
et al. (2006) – which they did not report. Schweinfurth et al. (2006) also acquired their 
specimens from the oropharynx and established their cultures in NIKS medium, rather than 
a serum-free keratinocyte growth media. Therefore, it is difficult to confidently make 
comparisons between these different experimental conditions. For our 'Phase I' study 
however, it is important to note that larger biopsy specimens had a greater probability of 
establishing a culture, which added a predictive factor to our methods. 
 When establishing normal cervical keratinocyte cultures from hysterectomies, Liu 
et al. (2013) reported a maximum in vitro lifespan of approximately 6 weeks: 2 weeks to 
establish cultures in T-25 flasks, and one week between passages. Importantly, subsequent 
passages were seeded at a 1:2 ratio from the previous passage, indicating a long doubling 
time. Similar results were achieved when culturing keratinocytes from CIN biopsy 
specimens, wherein cultures could again be passaged 1:2 up to four times (Liu et al., 2016). 
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Our 'Phase I' results seem comparable with this, but somewhat more variable: of 7 
proliferating cultures, 2 differentiated in the first T-12.5 flask, 3 differentiated in the first 
scale-up to a T-25, and 2 managed to be scaled up to a T-75 and passaged onto a second 
T-75. These results could be accounted for by biopsy size between research groups, slight 
methodological differences, or perhaps simply due to our larger sample size. 
 Though we felt our methodology was firmly established and our results reflected 
that of literature, we sought to improve culture conditions with the aim of increasing in 
vitro lifespan. We changed our culture media to EpiLife supplemented with HKGS, as this 
commercial media is rated for over twice as many population doublings versus 
conventional keratinocyte growth media (Li S et al., Cascade Biologics Inc). In addition, 
we added the ROCK inhibitor Y-27632, as this chemical inhibitor increases the in vitro 
lifespan of epithelial cells. In our method, the ROCK inhibitor was added after cultures 
were established in the presence of 5% FBS. This is because Y-27632 increases the growth 
rate of primary fibroblasts (Piltti et al., 2015), and could potentially increase fibroblast 
contamination when establishing keratinocyte colonies from the processed biopsy 
specimens. In the presence of J2 feeders, ROCK inhibition is also capable of immortalizing 
primary epithelial cells, and has been employed for generating primary breast and prostate 
cell lines (Gil et al., 2005), as well as keratinocytes (Chapman et al., 2011). For normal 
keratinocytes, ROCK inhibition alone increases total population doublings in vitro 
(Strudwicket al., 2015), and when combined with constitutive Myc or E6 expression, 
ROCK inhibition can immortalize keratinocytes. Although it is not fully understood, 
ROCK inhibition facilitates immortalization by reducing apoptosis and differentiation, in 
part by decreasing the expression of p53 target genes (Dakic et al., 2016). Therefore, we 
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hypothesized that ROCK inhibition should not only increase culture lifespan, but it may 
permit the immortalization of HPV-infected keratinocytes – as long as they continue to 
stably express E6. Despite this rationale, we did not obtain any immortalized cultures via 
this method. Additionally, keratinocyte subcultures recovered from cryopreserved stocks 
survived for just as many population doublings as their unpreserved counterparts (data not 
shown), suggesting that in vitro lifespan may be predetermined under these culture 
conditions. Interestingly, while the median lifespan, in weeks, remains largely unchanged, 
the switch to EpiLife containing Y-27632 drastically reduced the doubling time of 
keratinocytes, by roughly one half. Therefore, a subset of our established cultures 
proliferated for enough time – and with sufficient flask size-scaling – to yield ample cell 
numbers for downstream experimentation. Indeed, two cultures, AV6 and 3UI, reached 
passage numbers similar to that of commercially acquired keratinocytes. Interestingly, the 
patient information we acquired – age, lesion grade, and HPV type(s) – offered no real 
predictive value in establishing a proliferating culture. The biopsy size, and whether the 
biopsy was susceptible to collagenase digestion (i.e. yielding a turbid digest) were the most 
notable predictors of establishing cultures. 
 Although it was not tested in this study, future experiments should attempt to utilize 
J2 feeder layers in combination with Y-27632 to immortalize patient-derived keratinocyte 
cultures. The most prominent hurdle in utilizing feeders is the significant potential for 
fibroblast contamination. In this study, serum-free conditions drastically reduced the 
proliferation of residual fibroblasts; however, they were still visibly present in freshly 
established keratinocyte cultures. It was also evident that EpiLife increased fibroblast 
growth as compared to KGM, as it is a richer medium. We anticipate that residual 
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fibroblasts likely exist as a small percentage of the culture population for at least the first 
few passages. In two patient cultures, it was noted that the reintroduction of serum to less 
than 0.01% in an EpiLife background resulted in a rapid regrowth of fibroblasts (Figure 
A10). As standard feeder layers require serum, impure keratinocyte cultures remain the 
most prominent hurdle for immortalizing keratinocytes with feeders. It may be possible to 
serially dilute keratinocytes onto feeder layers to phase out their presence, or alternatively, 
cultures may need to be passaged several times before feeder layers can be introduced. 
Ideally, feeder layers and Y-27632 would be introduced as early as possible to ensure the 
long-term retention of patient cultures, and avoid the loss of otherwise successfully 
established cultures that possess too short a lifespan for experimental purposes. 
 
4.4 Organotypic raft culturing 
 In this study, we were unable to fully develop a raft protocol for these patient 
derived cell lines. In most instances, it appeared that the cultures had met their in vitro 
lifespan, as indicated by cell sizes and subsequent differentiation. Use of feeder-layers with 
Y-27632 may address this issue by conditionally immortalizing cells. Despite using the 
long-lived isolates for further method development, we were unable to achieve 
stratification. This result is in stark contrast to other cell lines and medias, where we have 
successfully grown raft cultures using primary human foreskin keratinocytes, NIKS 
immortalized keratinocytes (Jackson et al., 2014), and gingival keratinocytes – all of which 
where grown in different culture media prior to raft construction (data not shown). 
 It is interesting to note that there appeared to be invasion on patient culture IW9. 
This patient was shown to have an HPV16 positive, CINII-III lesion and is the highest 
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grade lesion we were able to establish a culture from in the second phase, and margins that 
resembled invasion were evident in all technical replicates. 
 
4.5 Future work 
 Future work should test different media formulations for raft cultures. Biomarkers 
relating to differentiation (eg. K5, K10, K14), as well as clinical markers relating to lesion 
grade (eg. p16INK4a, TOPO2a, MCM2) should be assessed, which may be corroborated both 
in the patient’s histology, and in the patient-derived raft in vitro. Eventually, patient-
derived raft cultures could be used to test novel therapeutics. Lechanteur et al. (2017) 
utilized lipid nanoparticles containing E7-targeting siRNA to treat raft cultures in vitro. 
Working with immortalized cell lines, Lechanteur et al., (2017) performed IHC on raft 
sections to stain for cell-cycle and apoptosis markers. In future work – with established 
methods for generating patient-derived raft cultures – it may be possible to test E6-targeting 
DsiRNA on patient-specific rafts, as a novel approach towards personalized medicine. 
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Figure A1. Screenshot of dot plot following Annexin V-FITC and propidium iodide 
staining for apoptosis analysis. Data was analyzed in Flowing Software 2.0 and statistical 
















Figure A2. Screenshot of workflow and histogram used in cell-cycle analysis. Data was 
analyzed in Flowing Software 2.0 and statistical summaries were exported and analyzed in 




Figure A3. Cell-cycle analysis of CaSki and SiHa 48 hours after transfection. Cultures 
were transfected with Rosetta DsiRNA or C9/11 DsiRNA control and harvested 48 hours 
later. Cells were stained with propidium iodide for flow cytometric analysis of cell cycle. 
No significant differences in cell-cycle phases was found between Rosetta and C9/11 






Figure A4. Cell-cycle analysis of CaSki and SiHa 96 hours after transfection. Cultures 
were transfected with Rosetta DsiRNA or C9/11 DsiRNA control and harvested 96 hours 
later. Cells were stained with propidium iodide for flow cytometric analysis of cell cycle. 
No significant differences in cell-cycle phases was found between Rosetta and C9/11 






Figure A5. Flow cytometry analysis of apoptotic events in CaSki at 48 hours. Cultures 
were treated with Rosetta or C9/11 DsiRNA. Apoptosis was measured using Annexin V – 
FITC and propidium iodide. No statistical changes in apoptosis were found for early (A), 





Figure A6. Flow cytometry analysis of apoptotic events in SiHa at 48 hours. Cultures 
were treated with Rosetta or C9/11 DsiRNA. Apoptosis was measured using Annexin V – 
FITC and propidium iodide. No statistical changes in apoptosis were found for early (A), 





Figure A7. Flow cytometry analysis of apoptotic events in CaSki at 96 hours. Cultures 
were treated with Rosetta or C9/11 DsiRNA. Apoptosis was measured using Annexin V – 
FITC and propidium iodide. No statistical changes in apoptosis were found for early (A), 






Figure A8. Flow cytometry analysis of apoptotic events in SiHa at 96 hours. Cultures 
were treated with Rosetta or C9/11 DsiRNA. Apoptosis was measured using Annexin V – 
FITC and propidium iodide. No statistical changes in apoptosis were found for early (A), 













Figure A9. Keratinocyte colonies seeded by fragments of partially digested tissue. 
Partially digested tissue fragments seed colonies in some patients (A and B), behaving as 




Figure A10. Fibroblast regrowth after the re-introduction of serum in the presence of 
EpiLife. Cultures were reseeded into EpiLife with Y-27632, from a 10 µl of cells 
suspended in NIKS medium, leftover from seeding raft cultures. At a final concentration 
of <0.01% FBS, fibroblasts regrew within a week. Colony of fibroblasts amongst 
differentiated keratinocytes from A1U (A) and fibroblast confluence in IW9 (B). Scale bar 
represents 200 microns.  
